C7orf28B Inhibitors belongs to a group of compounds specifically designed to modulate the activity of the C7orf28B protein. C7orf28B, also known as Chromosome 7 Open Reading Frame 28B, is a relatively lesser-known protein with limited information available regarding its precise function. However, researchers have identified that inhibiting C7orf28B may have potential implications in regulating certain cellular processes.
Structurally, C7orf28B Inhibitors are designed to interact with the C7orf28B protein, disrupting its normal activity. These inhibitors may function by binding to specific sites on the protein, altering its conformation, or interfering with its interactions with other cellular components. The development and study of C7orf28B Inhibitors contribute to our understanding of the molecular mechanisms associated with this protein. Researchers aim to unravel the biological pathways influenced by C7orf28B and investigate the potential impact of inhibiting its activity on cellular functions. Further studies and experiments are essential to elucidate the exact role of C7orf28B in cellular processes and to evaluate the implications that may arise from modulating its activity using inhibitors.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
A PARP inhibitor that may impact DNA repair mechanisms. If C7orf28B function is connected to DNA repair pathways, Olaparib could indirectly inhibit its activity. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that can prevent apoptosis. If the functional role of C7orf28B is associated with apoptotic signaling, inhibition of caspases could lead to reduced activity of C7orf28B. | ||||||